
Anthem Biosciences IPO IPO GMP Today
The Anthem Biosciences IPO IPO opens on 14 July 2025. Anthem Biosciences IPO IPO GMP is Rs 179.00 today. Listing price estimate is Rs 749.00 (issue price Rs 570.00). Listing gain estimate: 31.40%.
Issue Price
Rs 570.00
GMP Today
Rs 179.00
GMP %
+31.40%
Listing Price
Rs 749.00
Listing Gain / Lot
Rs 4,654.00
Listing Date
21 Jul 2025
Anthem Biosciences IPO IPO GMP Day Wise
GMP for Anthem Biosciences IPO started at Rs 0 on 30 June 2025 and stood at Rs 138 on 17 July 2025. The sharpest single-day jump was from Rs 0 on 7 Jul 2025 to Rs 66 on 8 Jul 2025. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 17 Jul 2025Today | Rs 570.00 | Rs 138.00 | Rs 708.00 (+24.21%) | Rs 3,588.00 |
| 16 Jul 2025 | Rs 570.00 | Rs 144.00 | Rs 714.00 (+25.26%) | Rs 3,744.00 |
| 15 Jul 2025 | Rs 570.00 | Rs 156.00 | Rs 726.00 (+27.37%) | Rs 4,056.00 |
| 14 Jul 2025 | Rs 570.00 | Rs 116.00 | Rs 686.00 (+20.35%) | Rs 3,016.00 |
| 13 Jul 2025 | Rs 570.00 | Rs 100.00 | Rs 670.00 (+17.54%) | Rs 2,600.00 |
| 12 Jul 2025 | Rs 570.00 | Rs 99.00 | Rs 669.00 (+17.37%) | Rs 2,574.00 |
| 11 Jul 2025 | Rs 570.00 | Rs 97.00 | Rs 667.00 (+17.02%) | Rs 2,522.00 |
| 10 Jul 2025 | Rs 570.00 | Rs 107.00 | Rs 677.00 (+18.77%) | Rs 2,782.00 |
| 9 Jul 2025 | Rs 570.00 | Rs 103.00 | Rs 673.00 (+18.07%) | Rs 2,678.00 |
| 8 Jul 2025 | Rs 570.00 | Rs 66.00 | Rs 636.00 (+11.58%) | Rs 1,716.00 |
| 7 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 6 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 5 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 4 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 3 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 2 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 1 Jul 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
| 30 Jun 2025 | Rs 570.00 | Rs 0.00 | Rs 570.00 (+0.00%) | Rs 0.00 |
Anthem Biosciences IPO IPO Listing Price
Based on today's GMP, Anthem Biosciences IPO IPO listing price estimate is Rs 749.00 per share (issue price Rs 570.00 + GMP Rs 179.00).
Actual listing price will be known on 21 July 2025 when the stock lists on NSE/BSE.
Anthem Biosciences IPO IPO Listing Gain
Lot size: 26 shares
GMP today: Rs 179.00
Estimated listing gain per lot: Rs 179.00 × 26 = Rs 4,654.00
A GMP of around 31.4% is a strong positive signal from the grey market. Investors are pricing in a meaningful listing premium over the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
Anthem Biosciences IPO IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Anthem Biosciences IPO is 67.42x. Compare this with the GMP trend to see if demand aligns. The GMP move around 8 Jul 2025 may reflect how the market reacted once the subscription window activity picked up after 14 Jul 2025.
See live figures on the Anthem Biosciences IPO IPO Subscription Status page.
Anthem Biosciences IPO IPO Details
| Field | Value |
|---|---|
| Price Band | ₹540.00-570.00 |
| Issue Size | ₹3395.00 Cr |
| Lot Size | 26 shares |
| IPO Type | Mainboard |
| Open Date | 14 Jul 2025 |
| Close Date | 16 Jul 2025 |
| Listing Date | 21 Jul 2025 |
| Subscription | 67.42x |
Anthem Biosciences IPO IPO full details (financials, peers, review).
About Anthem Biosciences IPO
Anthem Biosciences is a technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) for drug discovery, development and manufacturing. It offers comprehensive CRDMO services across the New Chemical Entity (NCE) and New Biological Entity (NBE) lifecycles. The company also manufactures and sells Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. As of March 31, 2024, the company had 550 customers in over 44 countries.
Anthem Biosciences IPO IPO GMP FAQs
What is the current GMP for Anthem Biosciences IPO?
The current GMP for Anthem Biosciences IPO is Rs 179 as of 25 June 2026, 9:47 PM IST. This is a premium of 31.40% over the issue price of Rs 570.
What is the estimated listing price based on current GMP?
The estimated listing price is Rs 749 per share, calculated as issue price (Rs 570) plus GMP (Rs 179). Actual listing price will be confirmed on 21 July 2025.
Will Anthem Biosciences IPO IPO list at the GMP price?
Anthem Biosciences IPO IPO may list around Rs 749 based on current GMP of Rs 179, but there is no guarantee it will list exactly at the grey market price. GMP is unofficial. The actual listing price on 21 July 2025 depends on market sentiment, subscription demand, and broader index levels on listing day. When subscription is strong and GMP holds steady after the IPO closes, listing price often comes close to the GMP estimate. Sharp GMP drops after subscription close have led to listings below the grey market price in the past.
What is the estimated profit per lot based on GMP?
At GMP of Rs 179 and lot size of 26 shares, estimated grey market profit is Rs 4,654 (1 lot x 26 shares x Rs 179). This is unofficial and not guaranteed.
What is GMP (Grey Market Premium)?
GMP is the premium at which IPO shares trade in the unofficial grey market before listing on NSE or BSE. It reflects informal demand and sentiment, not an exchange-set price.
How is GMP calculated?
Estimated listing price = issue price + GMP. GMP percentage = (GMP / issue price) x 100. Estimated profit per lot = GMP x lot size x minimum lots (2 for SME, 1 for mainboard).
Is GMP reliable for IPO investment decisions?
GMP is a sentiment indicator. Use it with subscription data, financials, valuation, and market conditions. It does not guarantee listing price or listing day gains.
Can GMP change before listing?
Yes. GMP can change between the close date (16 July 2025) and listing date (21 July 2025) based on market mood, news, and broader index movement.
What happens if GMP is negative?
Negative GMP suggests weak informal demand and possible listing below issue price. Actual listing may still differ.
How does GMP affect IPO subscription?
Rising GMP can attract more applications in the final hours of subscription. High GMP with weak fundamentals has still led to poor listings, so read subscription category-wise before applying.
Where can I track Anthem Biosciences IPO subscription and allotment?
Check Anthem Biosciences IPO IPO subscription status on IPOwiz for live category-wise bids. Allotment status can be checked from the allotment date on the IPOwiz allotment page.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. GMP verified before publish.